Aegis Capital Corp. Acted as Sole Bookrunner on a $8.5 Million Follow-On Offering for Medigus Ltd. (Nasdaq: MDGS)
Medigus Ltd. (Nasdaq: MDGS) successfully completed an $8.5 million follow-on offering, facilitated by Aegis Capital Corp. as the sole bookrunner. The funds raised will support Medigus' focus on medical devices and internet technologies, including its innovative surgical technology for treating GERD and miniaturized imaging equipment through its subsidiary Scoutcam. The offering aims to enhance Medigus' capabilities in both medical and digital sectors, reflecting the company's ambition for growth and innovation.
- Raised $8.5 million through a follow-on offering to support business expansion.
- Focus on innovative medical technologies and internet solutions.
- Partnership with Aegis Capital Corp. enhances financial strategy.
- None.
NEW YORK, NY / ACCESSWIRE / March 1, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a
About Medigus Ltd.
Medigus and its subsidiaries are focused on medical-related devices and products and on internet and other online-related technologies. Their medical-related activities include miniaturized imaging equipment through Scoutcam Inc. (formerly known as Intellisense Solutions Inc.), or Scoutcam, their
About Aegis Capital Corp.
Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research and sales and trading services to institutional investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services.
For more information about this offering or Investment Banking Services please email InvestmentBanking@aegiscap.com or call (212) 813-1010
This communication has been prepared by Aegis Capital Corporation for distribution to Aegis Capital Corporation's clientele. This communication is not intended for public dissemination and the recipient is prohibited from sharing this information. This communication has been prepared for institutional - accounts, as defined within FINRA Rule 4512(c), who (1) are capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities; and (2) will exercise independent judgment in evaluating the recommendations of any broker - dealer or its associated persons. This communication is not a product of Aegis Capital Corporation Research Department. Aegis Capital Corporation., Member FINRA, SIPC
SOURCE: Aegis Capital Corp.
View source version on accesswire.com:
https://www.accesswire.com/632785/Aegis-Capital-Corp-Acted-as-Sole-Bookrunner-on-a-85-Million-Follow-On-Offering-for-Medigus-Ltd-Nasdaq-MDGS
FAQ
What was the amount raised in Medigus' latest offering?
Who was the sole bookrunner for Medigus' follow-on offering?
What is Medigus focusing on with the funds raised from the offering?